GRK3 and neoplasm: LD2, a novel GRK3 inhibitor, actively reduced tumor cell growth, invasion, and tumor sphere formation in vitro in multiple GAC cell models and in vivo in a GAC PDX model with high GRK3 and YAP1 expression.